Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
The Next Frontier of CAR-T Cell Therapy: Solid Tumors
By Christine Filippis / April 4, 2019
The Technology has wowed the field by all but obliterating some patients' blood cancers, but sold malignancies present new challenges...
Read More
Miracle Elixirs
By Christine Filippis / April 4, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a...
Read More
It’s time for a worldwide moratorium on editing human embryos
By Christine Filippis / April 2, 2019
by Alan Trounson Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The...
Read More
